New vaginal capsule aims to tackle stubborn bacterial vaginosis

NCT ID NCT07663838

Not yet recruiting Disease control Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new drug called GenSci142, given as a vaginal capsule, for treating bacterial vaginosis (BV). About 30 women with BV will receive either GenSci142 or a standard antibiotic cream to compare safety and how well each works. The goal is to see if the new capsule is a safe and effective option for this common vaginal infection.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: GenSci142
What this could lead to: If successful, this could offer a new treatment option for bacterial vaginosis, potentially with fewer side effects or better long-term control.
What could go wrong: This is an early phase 1 trial with only 30 participants, so results may not apply broadly. The treatment may not prove more effective than existing options, and side effects are still being studied.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BACTERIAL VAGINOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bacterial vaginosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BACTERIAL VAGINOSIS OPEN LABEL PHARMACOKINETICS RANDOMIZED SAFETY TOLERABILITY

Contacts and locations

Locations

Beijing Tsinghua Changgung Hospital

Beijing, Beijing Municipality, 102218, China
Jiangxi Provincial Women and Children's Medical Center

Nanchang, Jiangxi, 330006, China
Nanjing Maternity and Child Health Care Hospital

Nanjing, Jiangsu, 210004, China
Shandong Provincial Hospital

Jinan, Shandong, 250001, China
The First Hospital of Jilin University

Changchun, Jilin, 130021, China
The Second Hospital of Shanxi Medical University

Taiyuan, Shanxi, 030001, China
Tianjin Medical University General Hospital

Tianjin, Tianjin Municipality, 300052, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.